410
Participants
Start Date
September 30, 2005
Study Completion Date
July 31, 2006
olmesartan alone or in combination with hydrochlorothiazide
Pfizer Investigational Site, Taipei
Pfizer Investigational Site, Taipei
Pfizer Investigational Site, Guei-Shan Shiang
Pfizer Investigational Site, Kaohsiung City
Pfizer Investigational Site, Khet Rajathevee
Pfizer Investigational Site, Bangkok
Pfizer Investigational Site, Jakarta
Pfizer Investigational Site, Bangkok
Pfizer Investigational Site, Jakarta
Pfizer Investigational Site, Haseki/Istanbul
Pfizer Investigational Site, Bornova/Izmir
Pfizer Investigational Site, Chiang Mai
Pfizer Investigational Site, Surabaya
Pfizer Investigational Site, Seremban
Pfizer Investigational Site, Kuching
Pfizer Investigational Site, Singapore
Pfizer Investigational Site, Singapore
Pfizer Investigational Site, Medellín
Pfizer Investigational Site, Barranquilla
Pfizer Investigational Site, Cartagena
Pfizer Investigational Site, Bogota
Pfizer Investigational Site, Santiago de Cali
Pfizer Investigational Site, Escobedo
Pfizer Investigational Site, Quito
Pfizer Investigational Site, NT
Pfizer Investigational Site, Shatin, NT
Pfizer Investigational Site, Jakarta
Pfizer Investigational Site, San Juan City
Pfizer Investigational Site, Quezon
Pfizer Investigational Site
Pfizer Investigational Site, S¿hhiye/Ankara
Pfizer Investigational Site, Sihhiye/Ankara
Lead Sponsor
Pfizer
INDUSTRY